Ispecimen inc (ISPC)
| Sector • Healthcare Industry • Medical Laboratories |
| Industry • Medical Laboratories |
| Sector • Healthcare |
Slight -4.97 %, revenue slide at Ispecimen Inc in the financial three months closing Sep 30 2022
Ispecimen Inc recorded third quarter of 2022 operating loss of $-3.101059 million
Published 2022-11-10T12:52:01+00:00
Goran Soko / CSIMarket.com Contributer
_[CC_BY-SA_4.0_httpscreativecommons.orglicensesby-sa4.0)].jpg "dna-163466__340")
Lower revenue led to diminishing Returns in the fiscal period ending September 30 2022, Revenue fell by -4.97 % to $2.58 million and deficit per share was at $-0.35 in proportion to $-0.22 per share realized in the quarter a year ago. Looking into earnings from the preceding quarter revenue advanced by 10.464 % from $2.34 million and increased deficit from $-0.30 per share.
For the fiscal period ending September 30 2022 Ispecimen Inc realized net deficit of $-3.096 million, bigger than $-1.553 million a year ago.
Ispecimen Inc is expected to report next financial earnings on August 03, 2023.